The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Ascendis Pharma(NASDAQ:ASND) 
Ascendis Pharma A/S, a biopharmaceutical company, develops therapeutics for unmet medical needs. The company develops TransCon growth hormone, which completed Phase III clinical trials for growth hormone deficiency. It also develops TransCon parathyroid hormone for adult hypoparathyroidism; and Tran...
Website: http://www.ascendispharma.com
Founded: 2006
Full Time Employees: 330
Sector: Healthcare
Industry: Biotechnology
Ascendis Pharma Days Payable Outstanding ttm (DPO)
Ascendis Pharma Days Receivable Outstanding ttm (DSO)
Ascendis Pharma Days Inventory Outstanding ttm (DIO)
Ascendis Pharma Op Cashflow Per Share ttm
Ascendis Pharma Free Cashflow Per Share ttm
Ascendis Pharma Cash Per Share ttm
Ascendis Pharma P/S ratio ttm
Ascendis Pharma (GAAP) P/E ratio ttm
Ascendis Pharma P/B ratio ttm
No extra charts and metrics for this ticker.